NEW YORK (GenomeWeb News) - Fluxion Biosciences said today that it has signed an exclusive agreement with Westburg under which the Leusden, Netherlands-based firm will market its BioFlux live cell image analysis platform in Belgium, the Netherlands, Luxembourg, Denmark, Finland, Iceland, Norway, and Sweden.
 
San Francisco-based Fluxion’s BioFlux 200 system is a microfluidic-based platform designed for live cell imaging in applications such as cell adhesion and microbial biofilm studies.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.